Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery (PLAN)
π©Ί Protocol Summary
Phase III, international multicentre, parallel group, blinded, 1:1 randomized controlled trial to determine the effect of an intraoperative intravenous lidocaine infusion on reducing the development of persistent pain 3-months after breast cancer surgery.
Primary Research Facility: Foothills Medical Centre (Calgary, Alberta)
π Preliminary Self-Screener
0 of 3 AnsweredAnswer all 3 basic criteria below to see your preliminary screening result:
π Primary Site Map
Site: Foothills Medical Centre β Calgary, Alberta
π All Participating Trial Locations (17 Sites)
Multi-Center TrialThis protocol is enrolling participants across multiple clinical centers:
π Print Doctor Discussion Sheet
Preview and print a 1-page summary with 5 tailored questions for your physician.
π° Clinical Trial Costs & Insurance Coverage
Coverage for clinical trial participation varies depending on your health insurance policy, state legislation, and whether specific procedures are investigational research or routine medical care. Under federal law (Affordable Care Act Β§ 2709), health insurers generally cannot drop coverage or refuse to pay for routine patient care costs incurred in approved clinical trials.
π‘ Always ask the study coordinator for the trial's official Informed Consent Form, which outlines all sponsor-funded research items versus procedures billed to your insurance.